Linda Palczuk - 15 Sep 2025 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as attorney-in-fact
Issuer symbol
AVDL
Transactions as of
15 Sep 2025
Net transactions value
$0
Form type
4
Filing time
15 Sep 2025, 19:54:41 UTC
Previous filing
31 Jul 2025
Next filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Palczuk Linda Director C/O AVADEL PHARMACEUTICALS PLC, 10 EARLSFORT TERRACE, DUBLIN 2, IRELAND /s/ Jerad G. Seurer, as attorney-in-fact 15 Sep 2025 0001717580

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Gift $0 -11,000 -100% $0.000000 0 15 Sep 2025 Ordinary Shares 11,000 $10.83 Direct F1
holding AVDL Stock Option (Right to Buy) 11,000 15 Sep 2025 Ordinary Shares 11,000 $10.83 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.
F2 On September 15, 2025, the Reporting Person transferred 11,000 options to a revocable trust of which the Reporting Person is trustee.